QUEBEC CITY, June 9 /PRNewswire-FirstCall/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the second quarter 2010 ended April 30, 2010. The Company announ